---
title: "China Resources Pharmaceutical: DEEJ's net profit for the first three quarters is 1.277 billion yuan, an increase of 10.77% year-on-year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262581763.md"
description: "According to the Zhitong Finance APP, China Resources Pharmaceutical announced its Dong'e Ejiao performance for the nine months ending September 30, 2025, with total operating revenue of RMB 4.766 billion, an increase of 4.41% year-on-year; net profit of RMB 1.277 billion, an increase of 10.77% year-on-year"
datetime: "2025-10-24T09:12:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262581763.md)
  - [en](https://longbridge.com/en/news/262581763.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262581763.md)
generator: "portal-rs"
---

# China Resources Pharmaceutical: DEEJ's net profit for the first three quarters is 1.277 billion yuan, an increase of 10.77% year-on-year

According to the Zhitong Finance APP, China Resources Pharmaceutical (03320) released the performance report of Dong'e Ejiao for the nine months ending September 30, 2025, with total operating revenue of RMB 4.766 billion, an increase of 4.41% year-on-year; net profit of RMB 1.277 billion, an increase of 10.77% year-on-year

### Related Stocks

- [000423.CN](https://longbridge.com/en/quote/000423.CN.md)

## Related News & Research

- [Alibaba’s AI Spending Spree Intensifies — Surprise Stock Sale Has Analysts Asking Why](https://longbridge.com/en/news/296767766.md)
- [Foreign worker numbers to stay controlled despite business pressure](https://longbridge.com/en/news/296762549.md)
- [EDM Announces Results of the Annual General Meeting | EDMFF Stock News](https://longbridge.com/en/news/296781083.md)
- [Cheng Shin Rubber: 2026H1 net income surged 43.8% year-over-year, driven by higher revenue and improved margins](https://longbridge.com/en/news/296745040.md)
- [Yangtze Memory clears IPO counseling acceptance, moving closer to a Shanghai listing](https://longbridge.com/en/news/296442569.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**